Skip to main content

WELLS FARGO & COMPANY/MN

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 72971 SAN FRANCISCO, CA

Position in NAMS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$611,307
+$582,498 QoQ
Shares Held
18,038
+1904.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#124
of 197 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in NAMS Over Time

Shares Held

Position Value (USD)

Derivatives in NAMS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$128,782
PutShares
3,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. NAMS ranks #169 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NAMS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $128,782 3,800
2026-06-30 $611,307 18,038
2026-03-31 $28,809 900
2025-12-31 $31,572 900
2025-09-30 $17,064 600
2025-06-30 $3,622 200
2025-03-31 $10,235 500
2024-12-31 $12,850 500
2024-09-30 $8,300 500
2024-06-30 $9,605 500
2024-03-31 $11,825 500
2023-12-31 $3,351 300
2023-09-30 $2,775 300
2023-06-30 $3,567 300